Nurix Therapeutics Stock Performance
as on September 24, 2026 at 6:59 am IST
Day's Low
Day's High
$23.85$25.52
0.08%
Downside
6.91%
Upside

52 Week's Low
52 Week's High
$8.20$28.23
65.67%
Downside
18.27%
Upside

Nurix Therapeutics share price movements today
- Previous Close
- $25.67
- Open
- $25.52
- Volume
- 941.5K
- Day's Low - High
- $23.85 - $25.52
- 52 Week Low - High
- $8.20 - $28.23
Nurix Therapeutics Historical Returns
- 1 Month Return
- -2.28 %
- 3 Month Return
- + 33.01 %
- 1 Year Return
- + 195.06 %
- 3 Year Return
- + 190.06 %
- 5 Year Return
- -21.86 %
Nurix Therapeutics Stock Fundamentals & Key Indicators
Check Nurix Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
-3.45
Dividend Yield
0.00%
PE Ratio (TTM)
-7.44
Industry PE ratio
0.00
PEG Ratio
0.28006202531024055
Return On Equity TTM
-76.09%
Nurix Therapeutics Stock Valuation
Track how Nurix Therapeutics P/E has moved over time to understand its valuation trends.
Nurix Therapeutics in the last 5 years
Lowest (-10.55x)
November 30, 2021
Industry (0.00x)
November 30, 2025
Today (-5.54x)
November 30, 2025
Highest (-2.35x)
November 30, 2023
Today’s Price to Earnings Ratio: -5.54x
Nurix Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Nurix Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $- | -21.86% | -7.44 | -165.51% | 0.00% | |
| Neutral | $- | -57.56% | -22.88 | -12.57% | 0.00% | |
| StrongBuy | $- | 180.48% | 29.73 | 86.04% | 0.00% | |
| Buy | $82.2B | 25.83% | 19.2 | 84.86% | 0.46% |
Stock Returns calculator for Nurix Therapeutics Stock including INR - Dollar returns
The Nurix Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Nurix Therapeutics investment value today
Current value as on today
₹2,95,784
Returns
₹1,95,784
(+195.78%)
Returns from Nurix Therapeutics Stock
₹1,74,368 (+174.37%)
Dollar Impact
₹21,416 (+21.42%)
Analyst Recommendation on Nurix Therapeutics Stock
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Nurix Therapeutics. Average target price of $33.7777777777778
Nurix Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Nurix Therapeutics Annual Profit & Loss
All numbers in Millions USD
Nurix Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Nurix Therapeutics Annual Cash Flow
All numbers in Millions USD
Nurix Therapeutics News & Key Events

Today's Timeline - 08 June
Mon, 05:18 PM
-Nurix Therapeutics shares surged 24% after announcing collaboration with Roche to develop bexobrutideg for cancer treatment.
Insights on Nurix Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 3 months, NRIX stock has moved up by 33.0%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 6.25M → 9.04M (in $), with an average increase of 30.9% per quarter
POSITIVE IMPACTBest in 3 Years

In the last 3 years, NRIX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 605.4% return, outperforming this stock by 410.3%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, -78.22M → -89.53M (in $), with an average decrease of 7.1% per quarter
About Nurix Therapeutics
| Organisation | Nurix Therapeutics |
| Headquarters | 1600 Sierra Point Parkway, Brisbane, CA, 94005, US |
| Industry | Biotechnology |
| CEO | Arthur T. Sands |
| E-voting on shares | Click here to vote |
FAQs
What is Nurix Therapeutics share price today?
Nurix Therapeutics share price today is $23.87 as on at the close of the market. Nurix Therapeutics share today touched a day high of $25.52 and a low of $23.85.
What is the 52 week high and 52 week low for Nurix Therapeutics share?
Nurix Therapeutics share touched a 52 week high of $28.23 on and a 52 week low of $8.20 on . Nurix Therapeutics stock price today i.e. is closed at $23.87,which is 15.44% down from its 52 week high and 191.28% up from its 52 week low.
How to invest in Nurix Therapeutics Stock (NRIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nurix Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nurix Therapeutics Shares that will get you 0.0628 shares as per Nurix Therapeutics share price of $23.87 per share as on September 24, 2026 at 1:29 am IST.
What is the minimum amount required to buy Nurix Therapeutics Stock (NRIX) from India?
Indian investors can start investing in Nurix Therapeutics (NRIX) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Nurix Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nurix Therapeutics share’s latest price of $23.87 as on September 24, 2026 at 1:29 am IST, you will get 0.4189 shares of Nurix Therapeutics. Learn more about
fractional shares .
What are the returns that Nurix Therapeutics has given to Indian investors in the last 5 years?
Nurix Therapeutics stock has given -21.86% share price returns and 29.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?